Drug Profile
P 3914
Alternative Names: P3914Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Piramal Life Sciences
- Developer Piramal Enterprises
- Class Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dental pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Dental-pain in India (PO, Tablet)
- 21 Nov 2012 Piramal Healthcare terminates a phase I trial in Dental pain in India (NCT01339156)
- 11 Apr 2012 Piramal Life Sciences suspends enrolment in its phase I trial for Dental pain in India